secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2025-10-02T23:59:59+00:00
Accession:  0001437749-25-030217
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia regains Nasdaq compliance; stock continues trading on Capital Market
------------------------------------------------------------------------------

- Received Nasdaq notice on Oct 1, 2025 confirming compliance with Listing Rule 5550(b)(1).
- Company improved balance sheet and raised new capital to meet equity requirements.
- Common stock (BCDA) will continue to trade on Nasdaq Capital Market without interruption.
- Resolution removes previous delisting risk associated with equity deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774925030217/0001437749-25-030217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774925030217/bcda20251001_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-030217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer